FDA OTC Switch Policy: Key Issue Is Crafting Labeling From Public Domain

FDA is considering holding a public meeting to discuss Rx-to-OTC switch issues to clarify the agency's current thinking on which prescription categories have the potential to move over-the-counter in the near future